These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 25595909)
1. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Rybak AP; Bristow RG; Kapoor A Oncotarget; 2015 Feb; 6(4):1900-19. PubMed ID: 25595909 [TBL] [Abstract][Full Text] [Related]
2. Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors. Mazzoleni S; Jachetti E; Morosini S; Grioni M; Piras IS; Pala M; Bulfone A; Freschi M; Bellone M; Galli R Stem Cells Transl Med; 2013 Sep; 2(9):678-89. PubMed ID: 23884639 [TBL] [Abstract][Full Text] [Related]
3. Expression analysis of putative stem cell markers in human benign and malignant prostate. Ugolkov AV; Eisengart LJ; Luan C; Yang XJ Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131 [TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer. Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395 [TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. Gao W; Wang Y; Yu S; Wang Z; Ma T; Chan AM; Chiu PK; Ng CF; Wu D; Chan FL Stem Cell Res Ther; 2022 May; 13(1):188. PubMed ID: 35526071 [TBL] [Abstract][Full Text] [Related]
6. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Rybak AP; Tang D Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214 [TBL] [Abstract][Full Text] [Related]
7. Patterns of stemness-associated markers in the development of castration-resistant prostate cancer. Federer-Gsponer JR; Müller DC; Zellweger T; Eggimann M; Marston K; Ruiz C; Seifert HH; Rentsch CA; Bubendorf L; Le Magnen C Prostate; 2020 Sep; 80(13):1108-1117. PubMed ID: 32628318 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of FAM84B during prostate cancer progression. Wong N; Gu Y; Kapoor A; Lin X; Ojo D; Wei F; Yan J; de Melo J; Major P; Wood G; Aziz T; Cutz JC; Bonert M; Patterson AJ; Tang D Oncotarget; 2017 Mar; 8(12):19218-19235. PubMed ID: 28186973 [TBL] [Abstract][Full Text] [Related]
9. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Deng Q; Tang DG Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606 [TBL] [Abstract][Full Text] [Related]
11. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer. Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway. Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296 [TBL] [Abstract][Full Text] [Related]